Purchase Order 75N93024P01204

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Experimental Pathology Laboratories, Inc. (EPL) for histopathology services to support 5 efficacy studies for viruses with pandemic potential, with options for up to 10 additional tissue pathology studies and 10 studies that also require slide preparation. The contract has a ceiling value of $803,683.20 and a completion date of September 24, 2025. EPL is a privately held, employee-owned contract research organization that specializes in providing toxicology pathology services to federal agencies. There is no set-aside designation for this unrestricted procurement. The contract supports NIAID's role in the Antiviral Program for Pandemics, a multiagency effort to combat viruses that could cause pandemics.